3.26 USD
▼-0.05-1.51%
盘后 3.56 0.00%
2026-09-16
市值
$2.80M
市盈率
—
EPS
-71.69
股息率
—
52 周区间
3.26 – 1,210.00
成交量
21.21K
Beta
-0.93
目标价
—
52W 低 3.2652W 高 1,210.00
价格走势
公司简介
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company’s technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company’s lead product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is bei...